NEU 2.32% $19.40 neuren pharmaceuticals limited

having worked in ASX top 5 and ASX 300 company corporate...

  1. 1,175 Posts.
    lightbulb Created with Sketch. 304
    having worked in ASX top 5 and ASX 300 company corporate functions, I disagree with the notion that analysts do not have special access to the management. All analysts have regular meetings with the management/investor relations and sense check their assumptions in the model in particular smaller companies. That's the reason 7 analysts covering NEU all have target price within the small range.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.